Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays

DOI: 10.1128/AAC.00943-18

Article Information

DOI

PubMed

Published By

History

^aDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
^bDepartment of Clinical Laboratory, Xiangya Hospital of Central South University, Changsha, Hunan, China
^cDivision of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA

Address correspondence to Robin Patel, patel.robin{at}mayo.edu.
Citation Yan Q, Karau MJ, Raval YS, Patel R. 2018. Evaluation of oritavancin combinations with rifampin, gentamicin, or linezolid against prosthetic joint infection-associated methicillin-resistant Staphylococcus aureus biofilms by time-kill assays. Antimicrob Agents Chemother 62:e00943-18. https://doi.org/10.1128/AAC.00943-18.

Rendering graph...